🇺🇸 FDA
Patent

US 6054449

Compounds and method for PDT of intimal hyperplasia and other diseases

expired A61KA61K41/0066A61K41/0071

Quick answer

US patent 6054449 (Compounds and method for PDT of intimal hyperplasia and other diseases) held by Miravant Pharmaceuticals, Inc. expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Miravant Pharmaceuticals, Inc.
Grant date
Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K41/0066, A61K41/0071, A61P, A61P17/06